Perceptions of the state policy environment and adoption of medications in the treatment of substance use disorders

Psychiatric Services

Volumn 63, Issue 1, 2012, Pages 19-25

  Knudsen, Hannah K ^a   Abraham, Amanda J ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; BUPRENORPHINE; DISULFIRAM; METHADONE; NALTREXONE;

ADOPTION; ADULT; ARTICLE; FEMALE; FUNDING; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAID; PRESCRIPTION; SINGLE STATE AGENCY; SUBSTANCE ABUSE; UNITED STATES;

ADULT; ALCOHOL DETERRENTS; DATA COLLECTION; DIFFUSION OF INNOVATION; DRUG UTILIZATION; EVIDENCE-BASED PRACTICE; FEMALE; FINANCING, GOVERNMENT; FORMULARIES AS TOPIC; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH POLICY; HUMANS; INFORMATION DISSEMINATION; LOGISTIC MODELS; MALE; MEDICAID; MIDDLE AGED; MULTIVARIATE ANALYSIS; NARCOTIC ANTAGONISTS; STATE HEALTH PLANS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 84857875819     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201100034     Document Type: Article

References (52)

1. Hanson GR, Leshner AI, Tai B: Putting drug abuse research to use in real-life settings. Journal of Substance Abuse Treatment 23:69-70, 2002 (Pubitemid 36151687)
2. McCarty D, Edmondson EA, Hartnett T: Charting a path between research and practice in alcoholism treatment. Alcohol Research and Health 29:5-10, 2006 (Pubitemid 44944817)
3. McCarty D, Gustafson D, Capoccia VA, et al: Improving care for the treatment of alcohol and drug disorders. Journal of Behavioral Health Services and Research 36:52-60, 2009
4. National Voluntary Consensus Standards for the Treatment of Substance Use Conditions: Evidence-Based Treatment Practices. Washington, DC, National Quality Forum, 2007. Available at www.qualityforum.org/Publications/2007/09/ National-Voluntary-Consensus-Standards-for-the- Treatment-of-Substance-Use- ConditionsEvidence-Based-Treatment-Practices.aspx
5. Tai B, Straus MM, Liu D, et al: The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment. Journal of Substance Abuse Treatment 38:S4-S13, 2010
6. Ducharme LJ, Knudsen HK, Roman PM: Trends in the adoption of medications for alcohol dependence. Journal of Clinical Pharmacology 26(suppl 1):S13-S19, 2006 (Pubitemid 44772725)
7. Knudsen HK, Ducharme LJ, Roman PM: The use of antidepressant medications in substance abuse treatment: the public-private distinction, organizational compatibility, and the environment. Journal of Health and Social Behavior 48:195-210, 2007
8. Knudsen HK, Ducharme LJ, Roman PM: The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters. Drug and Alcohol Dependence 87:164-174, 2007 (Pubitemid 46215923)
9. Knudsen HK, Ducharme LJ, Roman PM: Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors. Journal of Substance Abuse Treatment 30:363-373, 2006 (Pubitemid 43729149)
10. Cartwright WS, Solano PL: The economics of public health: financing drug abuse treatment services. Health Policy 66:247-260, 2003 (Pubitemid 37433957)
11. Chriqui JF, Terry-McElrath Y, McBride DC, et al: State policies matter: the case of outpatient drug treatment program practices. Journal of Substance Abuse Treatment 35:13-21, 2008 (Pubitemid 351753046)
12. Heinrich CJ, Fournier E: Dimensions of publicness and performance in substance abuse treatment organizations. Journal of Policy Analysis and Management 23:49-70, 2004 (Pubitemid 38544903)
13. Rogers EM: Diffusion of Innovations, 5th ed. New York, Free Press, 2003
14. Thomas CP, Wallack SS, Lee S, et al: Research to practice: adoption of naltrexone in alcoholism treatment. Journal of Substance Abuse Treatment 24:1-11, 2003 (Pubitemid 36315767)
15. Fuller BE, Rieckmann T, McCarty D, et al: Adoption of naltrexone to treat alcohol dependence. Journal of Substance Abuse Treatment 28:273-280, 2005 (Pubitemid 40592129)
16. Roman PM, Johnson JA: Adoption and implementation of new technologies in substance abuse treatment. Journal of Substance Abuse Treatment 22:211-218, 2002 (Pubitemid 34606039)
17. Ducharme LJ, Knudsen HK, Roman PM, et al: Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network. Journal of Substance Abuse Treatment 32:321-329, 2007 (Pubitemid 46661128)
18. Knudsen HK, Abraham AJ, Johnson JA, et al: Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment 37:307-312, 2009
19. Knudsen HK, Roman PM: Racial and ethnic composition as a correlate of medication availability within addiction treatment organizations. Sociological Focus 42:133-151, 2009
20. Knudsen HK, Roman PM, Oser CB: Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations. Journal of Addiction Medicine 4:99-107, 2010
21. Knudsen HK, Abraham AJ, Roman PM: Adoption and implementation of medications in addiction treatment programs. Journal of Addiction Medicine 5:21-27, 2011
22. Scott WR: Organizations: Rational, Natural, and Open Systems, 4th ed. Upper Saddle River, NJ, Prentice Hall, 1998
23. Granovetter M: Economic action and social structure: the problem of embeddedness. American Journal of Sociology 91: 481-510, 1985
24. Pfeffer J: New Directions for Organization Theory: Problems and Prospects. New York, Oxford University Press, 1997
25. Pfeffer J: A resource dependence perspective on intercorporate relations; in Intercorporate Relations. Edited by Mizruchi MS, Schwartz M. Cambridge, United Kingdom, Cambridge University Press, 1987
26. Fennell ML, Warnecke RB: The Diffusion of Medical Innovations: An Applied Network Analysis. New York, Plenum, 1988
27. DiMaggio PJ, Powell WW: The iron cage revisited: institutional isomorphism and collective rationality in organizational fields; in The New Institutionalism in Organizational Analysis. Edited by Powell WW, DiMaggio PJ. Chicago, University of Chicago Press, 1991
28. Mark TL, Coffey RM, McKusick D, et al: National Estimates of Expenditures for Mental Health Services and Substance Abuse Treatment, 1991-2001. Rockville, Md, Substance Abuse and Mental Health Services Administration, 2005
29. Kubiak SP, Arfken CL, Gibson ES: Departments of corrections as purchasers of community-based treatment: a national study. Journal of Substance Abuse Treatment 36:420-427, 2009
30. Garfield RL, Lave JR, Donohue JM: Health reform and the scope of benefits for mental health and substance use disorder services. Psychiatric Services 61: 1081-1086, 2010
31. Thomas CP, Garnick DW, Horgan WM, et al: Advancing performance measures for use of medications in substance abuse treatment. Journal of Substance Abuse Treatment 40:35-43, 2011
32. Rieckmann TR, Kovas AE, Fussell HE, et al: Implementation of evidence-based practices for treatment of alcohol and drug disorders: the role of the state authority. Journal of Behavioral Health Services and Research 36:407-419, 2009
33. Rieckmann T, Kovas AE, Rutkowski BA: Adoption of medications in substance abuse treatment: priorities and strategies of single state authorities. Journal of Psychoactive Drugs 6(suppl):227-238, 2010
34. Heinrich CJ, Hill CJ: Role of state policies in the adoption of naltrexone for substance abuse treatment. Health Services Research 43:951-970, 2008 (Pubitemid 351623961)
35. Ducharme LJ, Abraham AJ: State policy influence on the early diffusion of buprenorphine in community treatment programs. Substance Abuse Treatment, Prevention, and Policy 3:17, 2008
36. Abraham AJ, Roman PM: Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector. Journal of Studies on Alcohol and Drugs 71:460-466, 2010
37. Kasarabada ND, Hser YI, Parker L, et al: A self-administered instrument for assessing therapeutic approaches of drug-user treatment counselors. Substance Use and Misuse 36:273-299, 2001 (Pubitemid 32294919)
38. Long JS: Regression Models for Categorical and Limited Dependent Variables. Thousand Oaks, Calif, Sage, 1997
39. Allison PD: Missing Data. Thousand Oaks, Calif, Sage, 2002
40. Allison PD: Missing data; in The SAGE Handbook of Quantitative Methods in Psychology. Edited by Millsap RE, Maydeu- Olivares A. Thousand Oaks, Calif, Sage, 2009
41. Royston P: Multiple imputation of missing values: update. Stata Journal 5:188-201, 2005
42. Royston P: Multiple imputation of missing values: update of ice. Stata Journal 5:527-536, 2005
43. Ambler G, Omar RZ, Royston P: A comparison of imputation techniques for handling missing predictor values in a risk model with a binary outcome. Statistical Methods in Medical Research 16:277-298, 2007 (Pubitemid 47018663)
44. Barnard J, Rubin DR: Small sample degrees of freedom with multiple imputation. Biometrika 86:948-955, 1999
45. Royston P: Multiple imputation of missing values. Stata Journal 4:227-241, 2004
46. Berger P, Luckmann T: The Social Construction of Reality: A Treatise in the Sociology of Knowledge. Garden City, NY, Anchor, 1966
47. Evans AC, Rieckmann T, Fitzgerald MM, et al: Teaching the NIATx model of process improvement as an evidence-based process. Journal of Teaching in the Addictions 6:21-37, 2007
48. Roman PM, McCarty D: Assessment of Project Development in Cohort One of Advancing Recovery: A Multimethod Approach. Athens, Ga, University of Georgia, National Treatment Center Study, 2009. Available at www.uga.edu/ntcs/AREV.htm
49. Isett KR, Burnam MA, Coleman-Beattie B, et al: The state policy context of implementation issues for evidence-based practices in mental health. Psychiatric Services 58:914-921, 2007 (Pubitemid 47122868)
50. Magnabosco JL: Innovations in mental health services implementation: a report on state-level data from the US Evidence-Based Practices Project. Implementation Science 1:13, 2006
51. Isett KR, Burnam MA, Coleman-Beattie B, et al: The role of state mental health authorities in managing change for the implementation of evidence-based practices. Community Mental Health Journal 44:195-211, 2008 (Pubitemid 351839898)
52. Rinaldo D: 50-State Table: Medicaid Financing of Medication-Assisted Treatment for Opiate Addiction. Washington, DC, National Conference of State Legislatures, 2008. Available at www.ncsl.org/IssuesResearch/Health/ MATOpiate50StateTableMedicaid/tabid/14144/Default.aspx